Tower Research Capital (TRC)’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,940
| Closed | -$6K | – | 7024 |
|
|
2022
Q1 | $6K | Buy |
+1,940
| New | +$6K | ﹤0.01% | 5000 |
|
|
2021
Q4 | – | Sell |
-1,426
| Closed | -$6K | – | 6960 |
|
|
2021
Q3 | $6K | Buy |
+1,426
| New | +$6K | ﹤0.01% | 4812 |
|
|
2021
Q2 | – | Sell |
-1,976
| Closed | -$24K | – | 6168 |
|
|
2021
Q1 | $24K | Buy |
1,976
+650
| +49% | +$7.9K | ﹤0.01% | 3753 |
|
|
2020
Q4 | $19K | Sell |
1,326
-5,486
| -81% | -$78.6K | ﹤0.01% | 3917 |
|
|
2020
Q3 | $78K | Buy |
+6,812
| New | +$78K | ﹤0.01% | 3327 |
|